JP2004138610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004138610A5 JP2004138610A5 JP2003334210A JP2003334210A JP2004138610A5 JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5 JP 2003334210 A JP2003334210 A JP 2003334210A JP 2003334210 A JP2003334210 A JP 2003334210A JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pro245
- polypeptide
- pro245 polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6636497P | 1997-11-21 | 1997-11-21 | |
| US7893698P | 1998-03-20 | 1998-03-20 | |
| PCT/US1998/019437 WO1999014241A2 (en) | 1997-09-17 | 1998-09-17 | Compositions and methods for the treatment of immune related diseases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000522240A Division JP3497133B2 (ja) | 1997-11-21 | 1998-11-20 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004138610A JP2004138610A (ja) | 2004-05-13 |
| JP2004138610A5 true JP2004138610A5 (https=) | 2005-06-09 |
| JP4040004B2 JP4040004B2 (ja) | 2008-01-30 |
Family
ID=38175777
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000522240A Expired - Fee Related JP3497133B2 (ja) | 1997-11-21 | 1998-11-20 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
| JP2003334210A Expired - Fee Related JP4040004B2 (ja) | 1997-11-21 | 2003-09-25 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
| JP2003334209A Expired - Fee Related JP3950097B2 (ja) | 1997-11-21 | 2003-09-25 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
| JP2007056461A Expired - Lifetime JP4382827B2 (ja) | 1997-11-21 | 2007-03-06 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000522240A Expired - Fee Related JP3497133B2 (ja) | 1997-11-21 | 1998-11-20 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003334209A Expired - Fee Related JP3950097B2 (ja) | 1997-11-21 | 2003-09-25 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
| JP2007056461A Expired - Lifetime JP4382827B2 (ja) | 1997-11-21 | 2007-03-06 | Ａ−３３関連抗原およびそれらの薬理学的使用 |
Country Status (11)
| Country | Link |
|---|---|
| EP (3) | EP1032667B1 (https=) |
| JP (4) | JP3497133B2 (https=) |
| AT (3) | ATE410512T1 (https=) |
| AU (1) | AU735081B2 (https=) |
| CA (1) | CA2309358A1 (https=) |
| CY (1) | CY1108212T1 (https=) |
| DE (3) | DE69837897T2 (https=) |
| DK (2) | DK1481990T3 (https=) |
| ES (3) | ES2316175T3 (https=) |
| PT (2) | PT1481989E (https=) |
| WO (1) | WO1999027098A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000015797A2 (en) * | 1998-09-17 | 2000-03-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| WO2001019991A1 (en) * | 1999-09-15 | 2001-03-22 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US6951924B2 (en) | 1997-03-14 | 2005-10-04 | Human Genome Sciences, Inc. | Antibodies against secreted protein HTEBYII |
| US7968689B2 (en) * | 1997-03-07 | 2011-06-28 | Human Genome Sciences, Inc. | Antibodies to HSDEK49 polypeptides |
| US6878806B2 (en) | 1997-03-14 | 2005-04-12 | Human Genome Sciences, Inc. | Human secreted protein HTEEB42 |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7192589B2 (en) * | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| JP4897690B2 (ja) * | 2004-10-12 | 2012-03-14 | ジェネンテック， インコーポレイテッド | 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド |
| SG10201804008UA (en) | 2005-11-04 | 2018-06-28 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
| TW201716437A (zh) | 2006-11-02 | 2017-05-16 | 建南德克公司 | 人類化之抗-因子ｄ抗體及其用途 |
| AR066660A1 (es) | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| SG190596A1 (en) | 2008-05-06 | 2013-06-28 | Genentech Inc | Affinity matured crig variants |
| SG11201601044XA (en) | 2013-08-12 | 2016-03-30 | Genentech Inc | Compositions and method for treating complement-associated conditions |
| AU2015253042A1 (en) | 2014-05-01 | 2016-10-20 | Genentech, Inc. | Anti-factor D antibody variants and uses thereof |
| EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
| US10407510B2 (en) | 2015-10-30 | 2019-09-10 | Genentech, Inc. | Anti-factor D antibodies and conjugates |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873A (en) | 1846-12-05 | Im p rovem ent in loo ms fo r w e avi ng w re-gauz e | ||
| US191A (en) | 1837-05-08 | Machine for facing and dressing stone | ||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
| US4579827A (en) | 1983-03-11 | 1986-04-01 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| EP0199141A3 (en) | 1985-04-19 | 1988-07-20 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| WO1987005330A1 (en) | 1986-03-07 | 1987-09-11 | Michel Louis Eugene Bergh | Method for enhancing glycoprotein stability |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4973478A (en) * | 1987-07-20 | 1990-11-27 | Allelix Biopharmaceuticals, Inc. | Treating inflammation with hepatocyte stimulating factor interferon β2 |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| KR0154872B1 (ko) | 1987-12-21 | 1998-10-15 | 로버트 에이. 아미테이지 | 발아하는 식물종자의 아크로박테리움 매개된 형질전환 |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1990005537A1 (en) * | 1988-11-16 | 1990-05-31 | Brigham And Women's Hospital | Inhib, a factor which inhibits cytokine-activated leukocytes |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ES2096590T3 (es) | 1989-06-29 | 1997-03-16 | Medarex Inc | Reactivos biespecificos para la terapia del sida. |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| US5756096A (en) | 1991-07-25 | 1998-05-26 | Idec Pharmaceuticals Corporation | Recombinant antibodies for human therapy |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| DK0752248T3 (da) | 1992-11-13 | 2000-11-13 | Idec Pharma Corp | Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig |
| PT616812E (pt) | 1993-03-24 | 2000-04-28 | Berlex Biosciences | Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro |
| US5650295A (en) * | 1995-06-02 | 1997-07-22 | Human Genone Sciences, Inc. | Macrophage migration inhibitory factor-3 |
| US5665701A (en) | 1994-11-17 | 1997-09-09 | The Research Foundation Of State University Of New York | Platelet membrane glycoprotein F11 and polypeptide fragments thereof |
| AU706241B2 (en) * | 1995-05-04 | 1999-06-10 | City Of Hope | Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| US6458939B1 (en) | 1996-03-15 | 2002-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
| SE9604470D0 (sv) * | 1996-12-04 | 1996-12-04 | Tamas Bartfai Konsulting Ab | Transmembrane component of tight junction |
| AU6552198A (en) * | 1997-03-14 | 1998-09-29 | Human Genome Sciences, Inc. | 28 human secreted proteins |
| CA2283631A1 (en) * | 1997-03-21 | 1998-10-01 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| JP2001509372A (ja) * | 1997-07-10 | 2001-07-24 | スミスクライン ビーチャム コーポレーション | 血小板凝集に関与する細胞表面受容体であるヒトｆ１１抗原 |
| ES2312205T3 (es) * | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| DK1241180T3 (da) * | 1998-03-20 | 2008-12-01 | Genentech Inc | Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette |
-
1998
- 1998-11-20 AT AT98959543T patent/ATE410512T1/de not_active IP Right Cessation
- 1998-11-20 EP EP98959543A patent/EP1032667B1/en not_active Expired - Lifetime
- 1998-11-20 AT AT04010433T patent/ATE364049T1/de active
- 1998-11-20 CA CA002309358A patent/CA2309358A1/en not_active Abandoned
- 1998-11-20 DK DK04010433T patent/DK1481990T3/da active
- 1998-11-20 WO PCT/US1998/024855 patent/WO1999027098A2/en not_active Ceased
- 1998-11-20 DE DE69837897T patent/DE69837897T2/de not_active Expired - Lifetime
- 1998-11-20 AT AT04010432T patent/ATE393786T1/de active
- 1998-11-20 PT PT04010432T patent/PT1481989E/pt unknown
- 1998-11-20 PT PT04010433T patent/PT1481990E/pt unknown
- 1998-11-20 DE DE69839430T patent/DE69839430T2/de not_active Expired - Lifetime
- 1998-11-20 ES ES98959543T patent/ES2316175T3/es not_active Expired - Lifetime
- 1998-11-20 ES ES04010433T patent/ES2288649T3/es not_active Expired - Lifetime
- 1998-11-20 DK DK04010432T patent/DK1481989T3/da active
- 1998-11-20 ES ES04010432T patent/ES2305608T3/es not_active Expired - Lifetime
- 1998-11-20 EP EP08017468A patent/EP2014677A1/en not_active Withdrawn
- 1998-11-20 DE DE69840105T patent/DE69840105D1/de not_active Expired - Lifetime
- 1998-11-20 JP JP2000522240A patent/JP3497133B2/ja not_active Expired - Fee Related
- 1998-11-20 AU AU15324/99A patent/AU735081B2/en not_active Ceased
- 1998-11-20 EP EP04010433A patent/EP1481990B1/en not_active Expired - Lifetime
-
2003
- 2003-09-25 JP JP2003334210A patent/JP4040004B2/ja not_active Expired - Fee Related
- 2003-09-25 JP JP2003334209A patent/JP3950097B2/ja not_active Expired - Fee Related
-
2007
- 2007-03-06 JP JP2007056461A patent/JP4382827B2/ja not_active Expired - Lifetime
-
2008
- 2008-07-24 CY CY20081100774T patent/CY1108212T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004138610A5 (https=) | ||
| AU2017378492B2 (en) | Variant libraries of the immunological synapse and synthesis thereof | |
| AU2003302386B2 (en) | Compositions and methods for the treatment of immune related diseases | |
| KR100512819B1 (ko) | 종양 치료용 조성물 및 방법 | |
| EP1220905A2 (en) | Composition and methods for the treatment of immune related diseases | |
| JP2014528714A5 (https=) | ||
| JP2002508970A5 (https=) | ||
| US20030175900A1 (en) | Compositions and methods for the treatment of tumor | |
| CN102753579A (zh) | 抗钙粘着蛋白抗体 | |
| US7655781B2 (en) | Variants of human glycoprotein hormone alpha chain: compositions and uses thereof | |
| US20090148898A1 (en) | Human Ron-Related Gene Variant Associated With Cancers | |
| JP2004513614A5 (https=) | ||
| WO2003104474A2 (en) | Large deletions in human brca1 gene and use thereof | |
| JP2004535161A5 (https=) | ||
| JP2008507253A5 (https=) | ||
| CA2400638A1 (en) | 7 human ovarian and ovarian cancer associated proteins | |
| JP2004515215A5 (https=) | ||
| WO1991012272A1 (en) | Protein factor | |
| JP2002522021A5 (https=) | ||
| WO1999055716A1 (en) | A gene associated with nijmegen breakage syndrome, its gene product and methods for their use | |
| US7342109B2 (en) | Human kinase interacting protein 2 (KIP2)-related gene variant associated with cancers | |
| EP1895004A1 (en) | Human hippocalcin gene variant associated with cancers | |
| CA2501815A1 (en) | Compositions and methods for the treatment of tumor | |
| WO2000008468A1 (en) | Method of determining cell or tissue type by transmembrane receptor identifiers | |
| WO2003031652A1 (en) | Method of examining type i diabetes |